Roswell Park Cancer Institute ( Site 0192), Buffalo
Perlmutter Cancer Center at NYU Langone Hospital - Long Island ( Site 0208), Mineola
Laura and Isaac Perlmutter Cancer Center at NYU Langone ( Site 0108), New York
и уште 2

Се регрутираФаза 2

Возраст 18 и постари · Сите полови · Ажурирано 25.9.2026 · NCT06890884

A Study to Compare How Well Odronextamab Combined With Chemotherapy Works and How Safe it is Against Rituximab Combined With Chemotherapy, in Adult Patients With Previously Untreated Diffuse Large B-cell Lymphoma

Stony Brook University Hospital, Stony Brook

Се регрутираФаза 3

Возраст 18 и постари · Сите полови · Ажурирано 25.9.2026 · NCT06091865

A Study of LY4152199 in Participants With Previously Treated B-cell Malignancies (BAF_FRontier-1 )

New York University (NYU) Clinical Cancer Center, New York
Weill Cornell Medicine, New York
David H. Koch Center for Cancer Care at Memorial Sloan Kettering Cancer Center, New York

Се регрутираФаза 1

Возраст 18 и постари · Сите полови · Ажурирано 22.9.2026 · NCT07101328

A Study of LY4584180 in Adult Participants With Previously Treated Blood Cancers

Columbia University, New York
University of Rochester, Rochester

Се регрутираФаза 1

Возраст 18 и постари · Сите полови · Ажурирано 22.9.2026 · NCT07226843

Substudy 01A: Zilovertamab Vedotin in Pediatric and Young Adult Participants With Hematologic Malignancies or Solid Tumors (MK-9999-01A/LIGHTBEAM-U01)

Memorial Sloan Kettering Cancer Center ( Site 1010), New York
New York Medical College ( Site 1023), Valhalla

Се регрутираФаза 1/2

6 Months – 25 Years · Сите полови · Ажурирано 17.9.2026 · NCT06395103

A Study to Evaluate INCA036873 in Participants With Advanced Solid Tumors and Hematological Malignancies

Memorial Sloan Kettering Cancer Center, New York

Се регрутираФаза 1

Возраст 18 и постари · Сите полови · Ажурирано 15.9.2026 · NCT07195916

Evaluate Optimization of CRS Profile for Glofit Monotherapy and Glofit+GemOx in R/R Aggressive B-NHL

New York Oncology Hematology, P.C., Albany
Hematology Oncology Associates of Central New York, East Syracuse

Се регрутираФаза 2

Возраст 18 и постари · Сите полови · Ажурирано 11.9.2026 · NCT06806033

Testing the Combination of Nivolumab and ASTX727 for Relapsed or Refractory B-Cell Lymphoma

NYU Langone Hospital - Long Island, Mineola
Laura and Isaac Perlmutter Cancer Center at NYU Langone, New York

Се регрутираФаза 1

Возраст 18 и постари · Сите полови · Ажурирано 10.9.2026 · NCT05272384

A Study of ARC-02 in B-cell NHL

NYU Langone, New York

Се регрутираФаза 1

Возраст 18 и постари · Сите полови · Ажурирано 26.8.2026 · NCT07691606

Study of Rondecabtagene Autoleucel in Aggressive Large B-Cell Lymphoma

Roswell Park Comprehensive Cancer Center, Buffalo
David H. Koch Center for Cancer Care at Memorial Sloan Kettering Cancer Center, New York
Montefiore Medical Center, The Bronx

Се регрутираФаза 1/2

Возраст 18 и постари · Сите полови · Ажурирано 25.8.2026 · NCT05826535

Gene Therapy for CD19-Positive Hematologic Malignancies (SENTRY-CD19)

New York Medical College, Valhalla

Се регрутираФаза 1/2

Возраст од 13 до 90 · Сите полови · Ажурирано 6.8.2026 · NCT06533579

A Study to Investigate Ronde-cel Versus Investigator's Choice CD19 CAR T-Cell Therapy

Roswell Park Comprehensive Cancer Center, Buffalo

Се регрутираФаза 3

Возраст 18 и постари · Сите полови · Ажурирано 4.8.2026 · NCT07188558

A Study of Glofitamab-based Treatment in People With Diffuse Large B-cell Lymphoma

Memorial Sloan Kettering Cancer Center Suffolk - Commack (Limited Protocol Activities), Commack
Memorial Sloan Kettering Westchester (All Protocol Activities), Harrison
Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
и уште 1

Се регрутираФаза 2

Возраст од 65 до 80 · Сите полови · Ажурирано 22.7.2026 · NCT06765317

DALY II USA/ MB-CART2019.1 for DLBCL

Memorial Sloan Kettering Cancer Center, New York

Се регрутираФаза 2

Возраст 18 и постари · Сите полови · Ажурирано 13.7.2026 · NCT04792489

Immune Cell Therapy (CAR-T) for the Treatment of Patients With HIV and B-Cell Non-Hodgkin Lymphoma

Memorial Sloan Kettering Cancer Center, New York
Montefiore Medical Center - Moses Campus, The Bronx

Се регрутираФаза 1

Возраст 18 и постари · Сите полови · Ажурирано 10.7.2026 · NCT05077527

Autologous Stem Cell Transplant Followed by Polatuzumab Vedotin in Patients With B-cell Non-Hodgkin and Hodgkin Lymphoma

New York Medical Center, Valhalla

Се регрутираФаза 1/2

Возраст од 12 до 70 · Сите полови · Ажурирано 15.4.2026 · NCT04491370

Iomab-ACT: A Pilot Study of 131-I Apamistamab Followed by CD19-Targeted CAR T-Cell Therapy for Patients With Relapsed or Refractory B-Cell Acute Lymphoblastic Leukemia or Diffuse Large B-Cell Lymphoma

Memorial Sloan Kettering Suffolk - Commack (Limited Protocol Activities), Commack
Memorial Sloan Kettering Westchester (Limited Protocol Activities), Harrison
Memorial Sloan Kettering Cancer Center, New York
и уште 1

Се регрутираРана фаза 1

Возраст 18 и постари · Сите полови · Ажурирано 17.2.2026 · NCT04512716

Testing Drug Treatments After CAR T-cell Therapy in Patients With Relapsed/Refractory Diffuse Large B-cell Lymphoma

NYP/Columbia University Medical Center/Herbert Irving Comprehensive Cancer Center, New York
University of Rochester, Rochester
Wilmot Cancer Institute at Webster, Webster

Се регрутираФаза 2

Возраст 18 и постари · Сите полови · Ажурирано 2.2.2026 · NCT05633615

ctDNA-guided Therapy Optimization in Newly Diagnosed DLBCL

Columbia University, New York

Се регрутира

Возраст 18 и постари · Сите полови · Ажурирано 23.1.2026 · NCT06693830

A Study of Circulating Tumor DNA (ctDNA) Testing for People With B-Cell Lymphoma

Memorial Sloan Kettering Suffolk - Commack (Limited Protocol Activities), Commack
Memorial Sloan Kettering Westchester (Limited Protocol Activities), Harrison
Memorial Sloan Kettering Cancer Center (All Protocol Activites), New York
и уште 1

Се регрутираФаза 2

Возраст 18 и постари · Сите полови · Ажурирано 18.12.2025 · NCT06736613

A Study to Evaluate the Impact of Mosunetuzumab Consolidation for Older Patients With Diffuse Large B-cell Lymphoma (DLBCL) Who Have Detectable Amounts of ctDNA (Circulating Tumor DNA) at the End of Treatment With Pola-R-mini-CHP

Wilmot Cancer Institute, Rochester

Се регрутираФаза 2

Возраст 70 и постари · Сите полови · Ажурирано 20.10.2025 · NCT06828991

Study Adding Drugs to Usual Treatment for Large B-Cell Lymphoma That Returned or Did Not Respond to Treatment

NYP/Columbia University Medical Center/Herbert Irving Comprehensive Cancer Center, New York
University of Rochester, Rochester
Wilmot Cancer Institute at Webster, Webster

Се регрутираФаза 2

Возраст 18 и постари · Сите полови · Ажурирано 20.10.2025 · NCT05890352

Study of a Communication Training Intervention for Large B-Cell Lymphoma Providers

Memorial Sloan Kettering Cancer Center (All protocol activities), New York
NEW YORK PRESBYTERIAN HOSPITAL (Data Collection Only), New York

Се регрутира

Возраст 18 и постари · Сите полови · Ажурирано 9.10.2025 · NCT05940272

Obinutuzumab and ICE Chemotherapy in Refractory/Recurrent CD20+ Mature NHL

New York Medical College, Valhalla

Се регрутираФаза 2

Возраст од 3 до 31 · Сите полови · Ажурирано 8.8.2025 · NCT02393157

Epcoritamab Compared to Observation for Treating B-cell Lymphoma Patients Not in Complete Remission After CD19-directed CAR-T Therapy

Memorial Sloan Kettering Cancer Center, New York

Се регрутираФаза 2

Возраст 18 и постари · Сите полови · Ажурирано 26.9.2024 · NCT06238648

Од ClinicalTrials.gov, податоци преземени 6.10.2026. Секоја студија ги поставува своите услови за вклучување; тимот на студијата одлучува кој може да учествува.